CORBEIL-ESSONNES Cedex, France Clinical Trials

A listing of CORBEIL-ESSONNES Cedex, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 88 clinical trials
Transcranial Ultrasonography for the Management of Patients With Mild TBI

The investigators hypothesize that patients with mild TBI and normal TCD can be safely discharged home immediately after the ED. The targeted population is the category of patients eligible for early discharge: 1) patients with mild lesions on the initial CT scan and a GCS 15 after CT scan completion …

aspirin
anticoagulant
headache
vomiting
ct scan
CH Melun
 (9.5 away) Contact site
  • 4 views
  • 15 Apr, 2021
  • +21 other locations
Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over

Colorectal cancer occurs mainly in elderly patients. Recent estimation showed that in France more than 50% of the patients diagnosed with a colorectal cancer are 70 years old or more. Adjuvant chemotherapy has demonstrated a benefit on disease-free survival and overall survival after a stage III colon cancer resection. Nevertheless …

primary tumor
fluoropyrimidine
colon cancer
stage iii colon cancer
capecitabine
Centre Hospitalier Sud Francilien
 (1.1 away) Contact site
  • 31 views
  • 24 Jan, 2021
  • +202 other locations
Study to Improve OS in 18 to 60 Year-old Patients Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

This open label, multicenter phase II/III study with multiple randomization phases at differents stages of AML treatment (induction, consolidation and HSCT where applicable) is designed to improve OS in younger (18 to 60 year-old) patients, with AML risk-adapted patient strategies. Within the intermediate risk AML group, optimal GvHD prophylaxis following …

vosaroxin
venetoclax
cyclosporine
mycophenolate mofetil
consolidation chemotherapies
Centre Hospitalier Sud Francilien
 (0.0 away) Contact site
  • 42 views
  • 25 Jan, 2021
  • +56 other locations
STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction

In elderly patients 60yrs with acute ST-elevation myocardial infarction randomised within 3 hours of onset of symptoms the efficacy and safety of a strategy of early fibrinolytic treatment with half-dose tenecteplase and additional antiplatelet therapy with a loading dose of 300 mg clopidogrel, aspirin and coupled with antithrombin therapy followed …

stemi
aspirin
st elevation myocardial infarction
tenecteplase
myocardial infarction
CH Sud Francilien - Service Cardiologie
 (0.0 away) Contact site
  • 125 views
  • 23 Jan, 2021
  • +50 other locations
Myocardial Ischemia and Transfusion

The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.

stemi
ischemia
blood transfusion
infarct
red blood cell transfusion
Centre Hospitalier Sud Francilien
 (1.0 away) Contact site
  • 378 views
  • 31 Jul, 2021
  • +132 other locations
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. …

cardiovascular disease
body mass index
overweight or obesity
Novo Nordisk Investigational Site
 (1.1 away) Contact site
  • 7720 views
  • 18 Jul, 2021
  • +1164 other locations
Efficacy Safety and Tolerability of Nangibotide in Patients With Septic Shock

This is a randomized, double-blind, placebo-controlled dose-selection study in which two doses of nangibotide are tested versus placebo. All patients with a diagnosis of septic shock will be considered for study participation. All potential study patients will receive standard of care for the treatment of septic shock. After screening for …

resuscitation
lactic acid
blood lactate
vasoconstrictor
Centre Hospitalier de Melun
 (9.5 away) Contact site
  • 0 views
  • 11 Jul, 2021
  • +43 other locations
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients

The Ministry of Health has set the target of eradicating hepatitis C (HCV) in France by 2025. The goal is to validate the feasibility and value of conducting routine HCV screening in hospitalized patients.

CHIV
 (8.4 away) Contact site
  • 0 views
  • 24 May, 2021
  • +3 other locations
SEvoflurane for Sedation in ARds

This study evaluates whether a sedation with inhaled sevoflurane will decrease mortality and increase time off the ventilator at 28 days in patients with acute respiratory distress syndrome (ARDS). Half of the patients will receive inhaled sedation with sevoflurane and the other half will receive intravenous sedation with propofol.

respiratory symptom
respiratory failure
edema
acute respiratory distress
pao2
Hospital
 (9.5 away) Contact site
  • 0 views
  • 25 Jan, 2021
  • +21 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

stemi
acute coronary syndrome
myocardial infarction
arterial disease
stroke
2500107 - Centre Hospitalier Sud Francilien
 (0.0 away) Contact site
  • 1118 views
  • 01 Aug, 2021
  • +3430 other locations